BRIEF-United Therapeutics Announces Positive Results From Phase 1 Study Of Miroliverelap In Patients With Acute Liver Failure

Reuters
Jan 26
BRIEF-United <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announces Positive Results From Phase 1 Study Of Miroliverelap In Patients With Acute Liver Failure

Jan 26 (Reuters) - United Therapeutics Corp UTHR.O:

  • UNITED THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM PHASE 1 STUDY OF MIROLIVERELAP® IN PATIENTS WITH ACUTE LIVER FAILURE

  • UNITED THERAPEUTICS CORP - STUDY MET PRIMARY ENDPOINT OF SURVIVAL DURING TREATMENT

  • UNITED THERAPEUTICS CORP - NO UNEXPECTED SERIOUS ADVERSE EVENTS REPORTED

Source text: ID:nBw3mnsnza

Further company coverage: UTHR.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10